Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

DiamondPeak Stock Really Looks Quite Risky Here

By Larry Ramer, InvestorPlace Contributor
DiamondPeak stock looks like a risky investment, given the strength of Lordstown's competitor, Rivian, and Lordstown's close connections with Workhorse.

Steer Clear of ‘Stuck In Neutral’ General Electric Stock

By InvestorPlace Research Staff
Between pandemic headwinds, and a turnaround that's still a work-in-progress, there's not much reason to buy GE stock right now.

The Ship Has Already Sailed Far Away for Workhorse Stock

By Thomas Niel, InvestorPlace Contributor
With its Lordstown and Post Office catalysts fully priced-in, there's no reason to buy the pullback in WKHS stock.

Coca-Cola Is Treading Water, But It’s Still Too Expensive

By Mark R. Hake, CFA
Coca-Cola stock has gone nowhere for five years but its still expensive. It is up 7% annually over five years, but still at 24x earnings.

Hertz Stock Is Only Good for Deliberately Hurting Your Portfolio

By InvestorPlace Research Staff
Hertz stock was once a brief contrarian play for the extreme gambler. But now that the fundamentals are settling in, it’s best to avoid this nightmarish “opportunity.”

Don’t Get Silly When Looking at General Electric

By Chris Markoch, InvestorPlace Contributor
GE stock has been making large moves, mostly based on hopes for more economic stimulus. But any news, good or bad, is baked into the stock.

There Are Really Long Odds That Tilray Stock Makes a Comeback Soon

By Larry Ramer, InvestorPlace Contributor
The still-high valuation of Tilray stock, coupled with the sector's continued structural challenges, make the stock unattractive.

The Risk-to-Reward Proposition for Sorrento Has Gone Bad

By Will Ashworth, InvestorPlace Contributor
Sorrento Therapeutics shareholders witnessed SRNE stock gain 70% in the past month. The risk-to-reward proposition has gone from good to bad.   

When to Sell a Stock

By Louis Navellier, Editor, Growth Investor
When a stock's fundamentals are slipping, wait for an opportunity to sell into strength. Whenever you can, resist the urge to panic-sell a stock.

Investors Will Eventually Grow Tired of Fitbit’s Losses

By Mark R. Hake, CFA
Investors will eventually grow tired of Fitbit's losses and zero profit outlook. Fitbit stock has no chance of rising until it can produce higher revenue and positive FCF despite growing competition.

Oil Demand Is Nowhere Near Sustainable for Halliburton

By Josh Enomoto, InvestorPlace Contributor
After almost a year of dealing with the coronavirus pandemic, Americans are ready to get back to their normal routines. The only problem for HAL stock is, this demand is nowhere near enough to be considered sustainable for the oil industry.

7 Risky Stocks Still in Danger From Covid-19

By Ian Bezek, InvestorPlace Contributor
Following news that President Donald Trump tested positive for Covid-19, it is time to sell these seven risky stocks.

There Are No Good Reasons to Buy Wells Fargo Right Now

By Louis Navellier and the InvestorPlace Research Staff
Even if you liked financial stocks, there’s no good reason to jump into WFC stock. Interest rates will remain at near zero for years.

Just Stand Back and Watch as Hertz Stock Slips Into Worthlessness

By Faisal Humayun, InvestorPlace Contributor
Business is likely to remain depressed due to the pandemic impact. High balance sheet debt makes equity worthless in a liquidation scenario.

Inovio Pharmaceuticals Does Not Need Any More Misfortune

By Chris Markoch, InvestorPlace Contributor
INO stock is plummeting after the FDA put a hold on its INO-4800 vaccine candidate. But by the time Inovio resumes the trial, will a vaccine be needed?

Don’t Buy Marathon Oil Stock Despite Restored Dividend

By Louis Navellier and the InvestorPlace Research Staff
Marathon Oil announced a plan to reinstate its dividend and pay down debt, but MRO stock recovery is tied to hope oil prices rise.

Get Out of IBIO Stock Before It’s Too Late

By Joel Baglole, InvestorPlace Contributor
Since peaking at $7.45 per share in July, iBio's stock price has fallen further from its 52-week high as hopes fade for the company to make a meaningful impact towards a cure for Covid-19. Today, IBIO stock is trading at just over $2 a share, about the same level it was at in early March of this year. Investors would be wise to sell this stock now before its price falls even more in coming weeks.

Resist the Temptation to Buy BP Shares After the Crash

By Louis Navellier and the InvestorPlace Research Staff
As this oil major dramatically slashes its yield while the share price crashes, you have to wonder if there's any reason left to own BP stock.

3 Richly Priced Hydrogen Stocks in Danger of Bursting

By Thomas Niel, InvestorPlace Contributor
Hydrogen stocks have been some of the biggest winners in 2020, but these three richly priced plays could head lower in the near term.
Load More Articles